Clinical Trials · NCT04736108
Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- West China Hospital
- Enrollment
- 50
- Start date
- May 2021
- Locations
- 1 site, China
- Primary endpoint
- Pathologic Complete Response Rate（pCR）